Edward Hurwitz, Director at MacroGenics, holds 33.07K shares in MacroGenics (Ticker: MGNX), holds 0.00 shares in Applied Genetic Technologies (Ticker: AGTC), holds 91.08K shares in Dyne Therapeutics (Ticker: DYN). Most recently, Edward Hurwitz Bought ― shares of MacroGenics on Sep 01, 2023 for an estimated value of 73.65K.